Your legacy can help bring an end to CMT. Learn how a planned gift can make an impact for generations to come.
CMTA_2016_Annual_Report
Actio Biosciences Doses First Participant in Phase I Clinical Trial | Future Phase Ib Clinical Trial to Focus on CMT2C
…“This Phase I clinical trial is an important step forward for the CMT2C community and our CMTA-STAR Alliance Partner, Actio Biosciences,” said CMTA CEO Sue Bruhn, PhD. “CMT2C is a…
CMTA Summer 2025 Report | COMMUNITY IS EVERYTHING: REAL STORIES, REAL PROGRESS
…New CMTA Centers of Excellence: Nine new sites expanding expert CMT care Christina’s Walk 4 CMT: A young adult’s story of leadership and community CMTA Films Presents: Jonah Berger 2025…
CMTeen Dolphin Outing in PEOPLE Online
Dolphin lover and CMTeen Maddie Leard is helping the CMTA raise money for CMT research. The Charcot-Marie-Tooth Association is in the pages of PEOPLE online once again, with a story…
CMTA Announces Addition of Health Insurance Industry Veteran Wendy Arnone to the Board of Directors
The Charcot-Marie-Tooth Association (CMTA), the largest philanthropic funder of Charcot-Marie-Tooth disease (CMT) research aimed at bringing treatments and a cure to patients, is pleased to announce the appointment of health…
State College, PA CMTA Branch Meeting (Virtual) with Guest Speaker
06/26/2023 @ 7:00 pm – 8:00 pm – Please join us (via Zoom) for the State College, PA CMTA Branch meeting Monday, June 26th at 7:00 pm EST. We will gather virtually to welcome guest speaker, Elizabeth Ouellette from the CMTA Board of Directors. She will share with us information on “CMT and Emotional Wellness.” Elizabeth Ouellette has been with the CMTA for […]
CMTA Spring 2025 Report | EMPOWERING INDEPENDENCE: SMALL TOOLS, BIG IMPACT
…the CMTA Gadget Store’s curated selection of practical tools to advancements in genetic therapies and clinical trials through CMTA’s Strategy To Accelerate Research (CMTA-STAR), every step forward brings us closer…
CMTA Announces Participation in Seed Extension Round for Armatus Bio for Novel CMT1A Gene Therapy
First Investment from CMTA’s New Venture Philanthropy Arm The Charcot-Marie-Tooth Association (CMTA) today announced that it participated in the Seed Series Extension syndicate for Armatus Bio, Inc. (Armatus). Armatus is…
Could MRI Help Speed Up CMT1A Research? New Findings from Professor Mary M. Reilly, MBE
…progression in CMT1A and serve as a potential biomarker for clinical trials. The study, Longitudinal MRI Study in CMT1A: One-Year Changes Predict Long-Term Progression, followed 20 individuals with CMT1A over…
Statement from CMTA’s Chief Executive Officer, Sue Bruhn, PhD
Dear Members of the CMT Community, The Charcot-Marie-Tooth Association (CMTA) continues to prioritize the well-being of the CMT community. Advocating for improved access to care as well as the acceleration…